Table 1

Characteristics of patients according to tertiles of sNGALpre-op

n=1371sNGALpre-opp Value
First tertile
<135 ng/L
(n=457)
Second tertile
135 –<220 ng/L (n=456)
Third tertile
>220 ng/L (n=458)
Age/years75.4±7.076.1±6.176.6±6.60.03
Male (n (%))302 (66.2)342 (75.3)345 (75.8)0.001
Additive EuroSCORE6 (5–7)6 (5–7)6 (5–8)0.03
BMI/kg/m227.2±4.527.8±4.527.7±4.40.08
Current smoker (n (%))26 (5.7)28 (6.2)24 (5.3)0.45
Diabetes mellitus (n (%))112 (24.6)119 (26.2)124 (27.3)0.65
Dyslipidaemia (n (%))321 (70.4)331 (72.9)316 (69.5)0.50
Hypertension (n (%))345 (75.7)340 (74.9)353 (77.6)0.62
Previous MI (n (%))166 (36.4)189 (41.6)197 (43.3)0.09
Atrial fibrillation (n (%))70 (15.4)71 (15.6)82 (18.0)0.49
PVD (n (%))40 (8.8)32 (7.0)37 (8.1)0.63
Stroke51 (11.2)53 (11.7)51 (11.2)0.97
LVEF category (n (%))0.55
Good300 (68.8)296 (67.6)276 (63.6)
Moderate89 (20.4)93 (21.2)103 (23.7)
Poor47 (10.8)49 (11.2)55 (12.7)
Baseline creatinine/µmol/L83 (73–97)91 (76–108)95 (80–118)<0.001
eGFR at baseline/mL/min/1.73 m275 (62–90)71 (59–85)67 (53–82)<0.001
Cardiopulmonary bypass time/hour1.75 (1.39–2.20)1.72 (1.33–2.23)1.77 (1.35–2.35)0.34
Cross-clamp time/hour1.17 (0.80–1.55)1.12 (0.78–1.57)1.15 (0.83–1.63)0.26
CABG only (n (%))229 (50.2)243 (53.3)228 (50.1)0.55
CABG+valve surgery (n (%))227 (49.8)213 (46.7)227 (49.9)
Length of ITU stay2 (1–4)3 (1–5)3 (1–5)<0.001
Length of hospital stay9 (7–14)10 (7–16)12 (8–21)<0.001
AKI (any) (n (%))135 (30.5)186 (41.5)206 (45.9)<0.001
PMI112 (24.5)102 (22.4)118 (25.8)0.48
Stroke11 (2.4)5 (1.1)7 (1.5)0.29
Revascularisation1 (0.2)3 (0.7)2 (0.4)0.60
  • AKI, acute kidney injury; BMI, body mass index; CABG, coronary artery bypass graft surgery; eGFR, estimated glomerular filtration rate; EuroSCORE, European System for Cardiac Operative Risk Evaluation; ITU, intensive care unit; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PMI, perioperative myocardial infarction; PVD, peripheral vascular disease; RIC, remote ischaemic conditioning; sNGALpre-op, preoperative serum neutrophil gelatinase-associated lipocalin.